230 related articles for article (PubMed ID: 19158152)
21. Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
Huang X; Lei S; Zhu MF; Jiang RL; Huang LQ; Xia GL; Zhi YH
J Zhejiang Univ Sci B; 2013 May; 14(5):400-15. PubMed ID: 23645177
[TBL] [Abstract][Full Text] [Related]
22. Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
Yilmaz MB; Yontar C; Erdem A; Karadas F; Yalta K; Turgut OO; Yilmaz A; Tandogan I
Heart Vessels; 2009 Jan; 24(1):16-21. PubMed ID: 19165563
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
[TBL] [Abstract][Full Text] [Related]
24. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB
Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344
[TBL] [Abstract][Full Text] [Related]
25. Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
Wikström BG
Eur J Heart Fail; 2010 Aug; 12(8):893. PubMed ID: 20675671
[No Abstract] [Full Text] [Related]
26. Levosimendan use in several scenarios of acute heart failure.
Tavares M; Andrade AC; Mebazaa A
Arq Bras Cardiol; 2008 Mar; 90(3):211-5. PubMed ID: 18392402
[TBL] [Abstract][Full Text] [Related]
27. Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Madeira M; Caetano F; Almeida I; Fernandes A; Reis L; Costa M; Gonçalves L
Rev Port Cardiol; 2017 Sep; 36(9):619-625. PubMed ID: 28826934
[TBL] [Abstract][Full Text] [Related]
28. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
29. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
[TBL] [Abstract][Full Text] [Related]
30. [Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Prijić S; Rakić S; Nikolić L; Jovicić B; Stajević M; Vukomanović V; Kosutić J
Vojnosanit Pregl; 2011 Nov; 68(11):979-84. PubMed ID: 22191317
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
Nieminen MS; Akkila J; Hasenfuss G; Kleber FX; Lehtonen LA; Mitrovic V; Nyquist O; Remme WJ
J Am Coll Cardiol; 2000 Nov; 36(6):1903-12. PubMed ID: 11092663
[TBL] [Abstract][Full Text] [Related]
32. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
33. Levosimendan: a retrospective single-center case series.
Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA
J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721
[TBL] [Abstract][Full Text] [Related]
34. Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Tasal A; Erturk M; Uyarel H; Karakurt H; Bacaksiz A; Vatankulu MA; Turfan M; Sonmez O; Erdogan E; Ergelen M
J Cardiol; 2014 Jun; 63(6):418-23. PubMed ID: 24268422
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
[TBL] [Abstract][Full Text] [Related]
36. Can we believe in levosimendan?
Follath F
Arq Bras Cardiol; 2008 Mar; 90(3):146-7. PubMed ID: 18392391
[No Abstract] [Full Text] [Related]
37. Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Nanas JN; Papazoglou P; Tsagalou EP; Ntalianis A; Tsolakis E; Terrovitis JV; Kanakakis J; Nanas SN; Alexopoulos GP; Anastasiou-Nana MI
Am J Cardiol; 2005 Mar; 95(6):768-71. PubMed ID: 15757608
[TBL] [Abstract][Full Text] [Related]
38. Levosimendan compared with dobutamine in low output patients.
Nieminen MS
Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717
[TBL] [Abstract][Full Text] [Related]
39. [Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
Zhang YH; Qing EM; Zhang J; Huang Y; Lü R; Zhou Q; Wei BQ; An T; Qing P; Zou CH
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):555-8. PubMed ID: 22490161
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan: a review of its use in the management of acute decompensated heart failure.
Innes CA; Wagstaff AJ
Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
